e.g. Tata motors, Reliance MF, 500570

Remus Pharmaceuticals Ltd. - Research Center

Group () BSE data
 
Back to Company Page
Results:
Statement:

Profit loss account

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 63.50 45.03 24.72 18.42 11.92
Expenses
Material consumed 27.83 21.44 12.27 11.49 7.04
Manufacturing expenses - - - - -
Personnel expenses 6.56 5.47 3.49 3.00 2.86
Selling expenses - - - - -
Adminstrative expenses 9.06 7.57 4.89 3.17 1.63
Expenses capitalised - - - - -
Cost of sales 43.45 34.48 20.65 17.66 11.53
Operating profit 20.04 10.55 4.07 0.76 0.39
Other recurring income 3.69 1.58 0.72 0.81 0.85
Adjusted PBDIT 23.74 12.12 4.79 1.57 1.24
Financial expenses 0.32 0.23 0.09 0.04 0.04
Depreciation 0.90 0.48 0.15 0.18 0.11
Other write offs - - - - -
Adjusted PBT 22.52 11.41 4.55 1.36 1.09
Tax charges 5.71 2.91 1.16 0.33 0.28
Adjusted PAT 16.82 8.50 3.39 1.03 0.81
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 16.82 8.50 3.39 1.03 0.81
Earnigs before appropriation 30.71 14.08 6.42 3.04 2.01
Equity dividend 0.59 - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 30.12 14.08 6.42 3.04 2.01
Close
Add Remus Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Remus Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback